GABRB3, gamma-aminobutyric acid type A receptor subunit beta3, 2562
N. diseases: 139; N. variants: 56
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.080 | 15 | 26773694 | missense variant | G/A | snv | 2.9E-03 | 3.5E-03 |
|
Nervous System Diseases | 0.020 | 1.000 | 2 | 2008 | 2011 | ||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.020 | < 0.001 | 2 | 2007 | 2012 | |||||||
|
0.925 | 0.040 | 15 | 26772759 | missense variant | C/T | snv |
|
Nervous System Diseases | 0.020 | 1.000 | 2 | 2008 | 2012 | ||||||||
|
0.925 | 0.040 | 15 | 26683789 | intron variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 15 | 26773790 | intron variant | G/A;C;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 15 | 26575978 | intron variant | A/G | snv | 0.46 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 15 | 26553052 | intron variant | T/C | snv | 0.12 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 15 | 26773694 | missense variant | G/A | snv | 2.9E-03 | 3.5E-03 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
1.000 | 0.040 | 15 | 26577667 | intron variant | G/A | snv | 0.43 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 15 | 26584374 | intron variant | A/G | snv | 0.61 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
15 | 26758948 | intron variant | T/A | snv | 0.48 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
15 | 26793345 | intron variant | C/A | snv | 0.42 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
0.882 | 0.080 | 15 | 26773694 | missense variant | G/A | snv | 2.9E-03 | 3.5E-03 |
|
Nervous System Diseases | 0.020 | 1.000 | 2 | 2008 | 2011 | ||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.020 | < 0.001 | 2 | 2007 | 2012 | |||||||
|
0.925 | 0.040 | 15 | 26772759 | missense variant | C/T | snv |
|
Nervous System Diseases | 0.020 | 1.000 | 2 | 2008 | 2012 | ||||||||
|
1.000 | 15 | 26799458 | intron variant | A/C | snv | 0.59 |
|
0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
1.000 | 15 | 26712093 | intron variant | G/A | snv | 0.32 |
|
0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 15 | 26766994 | intron variant | C/T | snv | 0.32 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 15 | 26561149 | missense variant | G/A | snv |
|
0.700 | 1.000 | 11 | 2008 | 2017 | ||||||||||
|
0.724 | 0.200 | 15 | 26774621 | intron variant | A/G | snv | 0.15 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.882 | 0.080 | 15 | 26560943 | missense variant | C/T | snv | 2.8E-05 | 1.4E-05 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
1.000 | 15 | 26621395 | missense variant | T/C | snv |
|
0.700 | 1.000 | 1 | 2017 | 2017 |